{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:11:57Z","timestamp":1746159117841,"version":"3.40.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2,15]]},"DOI":"10.1097\/01.npr.0000441921.41557.50","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T08:42:31Z","timestamp":1389948151000},"page":"10-13","source":"Crossref","is-referenced-by-count":4,"title":["Intermittent explosive disorder"],"prefix":"10.1097","volume":"39","author":[{"given":"Laura G.","family":"Leahy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"6","key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.63.6.669","article-title":"The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication.","volume":"63","author":"Kessler","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"2-3","key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.psychres.2010.07.018","article-title":"Kawakami N; WMH-J 2002-2006 Survey Group. Epidemiological aspects of intermittent explosive disorder in Japan; prevalence and psychosocial comorbidity: findings from the World Mental Health Japan Survey 2002-2006.","volume":"186","author":"Yoshimasu","year":"2011","journal-title":"Psychiatry Res"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2011.00001","article-title":"Impulse control disorders: updated review of clinical characteristics and pharmacological management.","volume":"2","author":"Schreiber","year":"2011","journal-title":"Front Psychiatry"},{"issue":"5","key":"R5-3-20210130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4088\/JCP.08m04150","article-title":"A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder.","volume":"70","author":"Coccaro","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.31887\/DCNS.2009.11.4\/kevers","article-title":"Personalized medicine in psychiatry: ethical challenges and opportunities.","volume":"11","author":"Evers","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"R8-3-20210130","first-page":"19","article-title":"Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy.","volume":"5","author":"Kenna","year":"2012","journal-title":"Pharmagenomics Pers Med"},{"issue":"4","key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euroneuro.2011.10.003","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy.","volume":"22","author":"Porcelli","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/mp.2008.116","article-title":"Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.","volume":"15","author":"Kato","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"1","key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0031-6997(24)01483-2","article-title":"Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.","volume":"53","author":"Strange","year":"2001","journal-title":"Pharmacol Rev"},{"issue":"4","key":"R12-3-20210130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/6.4.577","article-title":"A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia.","volume":"6","author":"Arinami","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"7","key":"R13-3-20210130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1176\/appi.ajp.2009.09040598","article-title":"D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.","volume":"167","author":"Zhang","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"9","key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/FPC.0b013e32833ca24b","article-title":"DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia.","volume":"20","author":"Lencz","year":"2010","journal-title":"Pharmacogenet Genomics"},{"issue":"209","key":"R15-3-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-3-642-24716-3_16","article-title":"5-HT(2C) receptor agonists and the control of appetite.","author":"Halford","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"4-5","key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0028-3908(97)00049-X","article-title":"RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist.","volume":"36","author":"Bonhaus","year":"1997","journal-title":"Neuropharmacology"},{"issue":"9323","key":"R17-3-20210130","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0140-6736(02)08913-4","article-title":"Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism.","volume":"359","author":"Reynolds","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/tpj.2009.18","article-title":"Olanzapine-induced weight gain is associated with the -759CT and -697GC polymorphisms of the HTR2C gene.","volume":"9","author":"Godlewska","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"3","key":"R19-3-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1176\/appi.ajp.162.3.613","article-title":"Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain.","volume":"162","author":"Buckland","year":"2005","journal-title":"Am J Psychiatry"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000441921.41557.50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:47:32Z","timestamp":1746114452000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006205-201402000-00003"}},"subtitle":["A study in personalized psychopharmacotherapy"],"short-title":[],"issued":{"date-parts":[[2014,2,15]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000441921.41557.50","relation":{},"ISSN":["0361-1817"],"issn-type":[{"type":"print","value":"0361-1817"}],"subject":[],"published":{"date-parts":[[2014,2,15]]}}}